Who founded Synkrino Biotherapeutics?

Synkrino Biotherapeutics was founded by Jason Barbour, David Ott.

Who are Synkrino Biotherapeutics's investors?

Synkrino Biotherapeutics's investors include Blue Bear Ventures, Y Combinator.

Synkrino Biotherapeutics is headquartered in San Francisco, US.

San Francisco, US · 2 employees · 2 known investors

90 people in our graph share verified history with the Synkrino Biotherapeutics team — schools, employers, funds. One of them is your warm intro.

×7knows the team · via University of Colorado Boulder

×3knows the team · via City College of San Francisco

knows the team · via University of New Haven

Also known as SF17 Therapeutics

Jason BarbourinFounder/CEO

David Ott inData Scientist, Co-Founder2017–2024He brings expertise in data science and machine learning to the field.

Who founded Synkrino Biotherapeutics?: Synkrino Biotherapeutics was founded by Jason Barbour, David Ott.
Who are Synkrino Biotherapeutics's investors?: Synkrino Biotherapeutics's investors include Blue Bear Ventures, Y Combinator.
Where is Synkrino Biotherapeutics headquartered?: Synkrino Biotherapeutics is headquartered in San Francisco, US.